telemedicine services offering compounded semaglutide treatments for weight loss management now available patients in California, Arizona, Hawaii and Florida Padgett Medical Center | Medical

Clinical trials with GLP-1 receptor agonists consistently demonstrate significant weight loss, with higher doses (such as semaglutide 2.4 mg weekly) producing approximately 15% average weight loss in adults without diabetes in clinical trials (somewhat less in type 2 diabetes) when combined with lifestyle modification

Henry Blooms Acetyl-L-Carnitine helps to: Support energy levels Support general health and wellbeing Aid metabolism of fat Assist synthesis of neurotransmitters Adults: Add 1 g (approx

Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer

A p-value of less than 0.05 was considered statistically significant

Unexplained weight loss beyond expected therapeutic effects, or inability to maintain adequate nutrition